Vimarsana
Biggest News Aggregation in the World

Acting Science Advisor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acting Science Advisor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acting Science Advisor Today - Breaking & Trending Today

Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals - Vimarsana News

Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals

/PRNewswire/ -- Sentynl Therapeutics, Inc. (Sentynl), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. (Zydus Group), and Eiger...

GOPers want Pentagon probe into over $50M spent on China pandemic research labs - Vimarsana News

GOPers want Pentagon probe into over $50M spent on China pandemic research labs

Sen. Joni Ernst (R-Iowa) and Rep. Mike Gallagher (R-Wis.) are demanding the Pentagon’s inspector general probe more than $50 million in defense grants given to Chinese pandemic research institutions — including those provided to labs in Wuhan, the city where COVID-19 first emerged in 2019.

Source: nypost.com
First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Progeria Receives Approval in Japan - Vimarsana News

First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Progeria Receives Approval in Japan

/PRNewswire/ -- The Progeria Research Foundation (PRF) today announced a new milestone with the approval of Zokinvy™ (lonafarnib) by the Japanese Ministry of...

Reflections from Dr. Francis Collins on the 20th Anniversary of the Human Genome Project - Vimarsana News

Reflections from Dr. Francis Collins on the 20th Anniversary of the Human Genome Project

To highlight how far the field of genetics has come, we spoke with Dr. Francis Collins, the leader of the Human Genome Project about his incredible career in genetics.

CyanVac CEO Speaks at White House Summit on the Future of COVID-19 Vaccines - Vimarsana News

CyanVac CEO Speaks at White House Summit on the Future of COVID-19 Vaccines

/PRNewswire/ -- CyanVac LLC, a clinical-stage biotechnology company developing intranasal vaccines using a proprietary transformational parainfluenza virus 5...